Dividends Calendar Earnings Calendar
NBIX

NBIX | Neurocrine Biosciences Inc

Neurocrine Biosciences Inc
Category: Consumer goods
  • Industry: Drug Manufacturers - Major

Quick infos

  • Headquarters:   San Diego, California, United States

Trade prices

  • Volume:
  • Market Cap: 9.49B
  • Prev closed:
  • Open:
  • High:
  • Low:
  • 52 week low:
  • 52 week high:
  • Dividends:No Dividends

Next ER: August 4, 2022  After Market Closes



Top Stories (NBIX)

    About the Company

    Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 1, 2022
    August 4, 2022-0.18 / 0.6167378.2M / 341.44MBeat!
    May 4, 20220.14 / 0.3468310.6M / 304.07MBeat!
    February 11, 2022-0.08 / 0.6775312M / 317.49M
    November 1, 20210.23 / 0.5568296M / 297.83M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 4, 2022 95.93 94.21
    96.63
    94.21
    577.61K 1.99%
    Aug 3, 2022 94.06 93.49
    95.27
    93.20
    624.63K 1.49%
    Aug 2, 2022 92.68 92.00
    93.07
    91.89
    457.39K 0.71%
    Aug 1, 2022 92.03 93.98
    94.56
    91.75
    548.25K -2.23%
    Jul 29, 2022 94.13 93.83
    94.28
    92.08
    737.01K 0.24%
    Jul 28, 2022 93.90 95.87
    95.87
    91.53
    537.89K -1.73%
    Jul 27, 2022 95.55 94.47
    95.81
    93.75
    373.00K 1%
    Jul 26, 2022 94.60 95.90
    96.23
    94.14
    440.37K -0.68%
    Jul 25, 2022 95.25 95.53
    96.02
    94.05
    441.20K -0.04%
    Jul 22, 2022 95.29 97.65
    98.74
    94.86
    605.12K -2.37%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1992
    • Employees:700

    News

    News for (NBIX)

    This company doesn't provide a dividend.


    Talk about Neurocrine Biosciences Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 4, 2022 (Same day)

    baba syna tm gpro newr clls trip w z swks k expe 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 63
    HOLD 31
    SELL 6

    Their Official Profiles 

    WikipediaLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Swing Trading For Dummies
    Buy on Amazon

    Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.

    Take advantage of price swings in strongly trending securities and pump up your portfolio!